Table S1.
Basic characteristics of 12 HCC cohort from GEO
| Cohort ID | Platform | Number of samples
|
Publication year | Country | |
|---|---|---|---|---|---|
| Nontumor | Tumor | ||||
|
| |||||
| GSE6764 | Affymetrix | 40 | 35 | 2007 | USA |
| GSE10143 | DASL | 307 | 80 | 2008 | USA |
| GSE14520 | Affymetrix | 220 | 225 | 2010 | USA |
| GSE25079 | Affymetrix | 289 | 268 | 2011 | USA |
| GSE36376 | Illumina | 193 | 240 | 2012 | South Korea |
| GSE39791 | Illumina | 72 | 72 | 2014 | USA |
| GSE57957 | Illumina | 39 | 39 | 2014 | Singapore |
| GSE60502 | Affymetrix | 18 | 18 | 2015 | Taiwan, ROC |
| GSE62232 | Affymetrix | 10 | 81 | 2014 | France |
| GSE64041 | Affymetrix | 65 | 60 | 2016 | Switzerland |
| GSE76297 | Affymetrix | 151 | 153 | 2017 | USA |
| GSE84005 | Affymetrix | 38 | 38 | 2017 | China |
| Total | 1,442 | 1,309 | |||
Abbreviations: GEO, Gene Expression Omnibus; HCC, hepatocellular carcinoma.